Modit Therapeutics

Novo Nordisk Research Centre China (NNRCC) and the innovation incubator ATLATL jointly announced the winners of the EntreStar program, a competition for China-based pharma start-ups. The winners were Hangzhou DNano MetaBio Technology and Modit Therapeutics both of which stand to receive RMB 500,000 (USD 71,550) and gain free access to…